Skip to main content
. Author manuscript; available in PMC: 2018 Feb 19.
Published in final edited form as: Brain Res Bull. 2016 Apr 29;126(Pt 1):111–126. doi: 10.1016/j.brainresbull.2016.04.011

Table 3.

Behavioral and toxic effects of MDPV and MDPV analogs compared to racemic amphetamine (Benzedrine®). Data obtained and adapted from patents related to MDPV (FR 5502, GB 1,149,366 and DE 1,545,591).

a MDPV α-alkyl group Zac LD50d Je
n-Propyl (i.e. MDPV) 0.20 175 875
isoPropyl 0.96 285 296
n-Butyl 0.54 250 463
f Benzedrine 1.95 80 42
a

Doses refer to base dose.

b

Z = dose required for stimulation of the central nervous system mg/kg (mouse, s.c.).

c

It is unclear if value represents minimal effective dose (MED), effective dose 50% (ED50), or other representative score.

d

LD50 = lethal dose 50%, toxicity in mg/kg (mouse) s.c.

e

J = (potential) therapeutic index = LD50/Z.

f

Benzedrine® [(±)-amphetamine] was used as reference CNS stimulant.